Xr Securities LLC Amgen Inc Transaction History

Xr Securities LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $3.86 Million - $4.66 Million	14,357 New	14,357 $4.08 Million
Q4 2022 Jan 03, 2023	SELL	$229.03 - $291.01 $4,580 - $5,820	-20 Reduced 0.94%	2,103 $552,000
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $476,528 - $537,437	2,123 New	2,123 $479,000
Q1 2022 Apr 14, 2022	SELL	$219.27 - $242.57 $375,609 - $415,522	-1,713 Closed	0 $0
Q4 2021 Jan 10, 2022	BUY	$198.88 - $227.6 $340,681 - $389,878	1,713 New	1,713 $385,000
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $210,571 - $246,710	-992 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$233.58 - $259.14 $231,711 - $257,066	992 New	992 $242,000
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $258,081 - $300,751	-1,163 Closed	0 $0
Q4 2020 Jan 13, 2021	SELL	$216.38 - $257.67 $809,044 - $963,428	-3,739 Reduced 76.27%	1,163 $267,000
Q3 2020 Oct 28, 2020	BUY	$234.65 - $260.95 $1.15 Million - $1.28 Million	4,902 New	4,902 $1.25 Million
Q3 2018 Oct 04, 2018	SELL	$185.29 - $208.89 $220,309 - $248,370	-1,189 Closed	0 $0
Q2 2018 Jul 06, 2018	BUY	$166.05 - $186.51 $197,433 - $221,760	1,189 New	1,189 $219,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.